Clinical Trial Update: Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating allogeneic stem cell transplantation with alpha/beta T and B cell depletion for hematologic malignancies; the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Myelodysplastic Syndromes

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Leukemia, Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING